Terumo India, subsidiary of Japan-based Terumo Corporation announced the launch of FineGlide™, Sterile Pen Needle for patients requiring regular insulin injections or other self-medication.
This device is the first product from the Life Care Solutions division of Terumo Medical Care Solutions launched in India. It is a super sharp needle with a silicone surface so it provides better penetration requiring lesser injection force when compared with other options in the market, according to the company.
78 million patients in India have diabetes, of which about 12% require insulin daily to manage the disease. There are other therapies where self-injection pen devices require these needles for drug delivery.
Ashit Sikka, director, Terumo Pharmaceutical Solutions, said, “With a growing number of patients requiring sub-Q delivery of medication for diverse medical conditions on a regular basis, the need for self-injection is growing significantly, both in India and globally. It is therefore important that patients/caregivers are empowered to manage drug administration accurately, yet conveniently. We believe that FineGlide™ provides patients with a much-needed option.”
Terumo India was established in 2013 with headquarters in Gurgaon, NCR Delhi.
